Clinical trial
The Long-term Outcome of Patients With Ulcerative Colitis Treated With First Trial of Biological.
NCT05530122 is registered in ClinicalTrials.gov with Tampere University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Long-term Outcome of Patients With Ulcerative Colitis Treated With First Trial of Biological.
- Lead sponsor
- Tampere University Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2009
- Completion date
- August 26, 2022
- Enrollment
- 192 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
ulcerative colitis